Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer
Authors
Keywords
Cancer treatment, Lesions, Oncology, Cancer detection and diagnosis, Magnetic resonance imaging, Endocrine therapy, Phase III clinical investigation, Randomized controlled trials
Journal
PLoS One
Volume 15, Issue 4, Pages e0227256
Publisher
Public Library of Science (PLoS)
Online
2020-04-22
DOI
10.1371/journal.pone.0227256
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of Health Care Databases to Support Supplemental Indications of Approved Medications
- (2018) Michael Fralick et al. JAMA Internal Medicine
- Multidimensional Evidence Generation and FDA Regulatory Decision Making
- (2017) Jonathan P. Jarow et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Real-world Data for Clinical Evidence Generation in Oncology
- (2017) Sean Khozin et al. JNCI-Journal of the National Cancer Institute
- From Trial to Target Populations — Calibrating Real-World Data
- (2017) Mehdi Najafzadeh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-world Data for Clinical Evidence Generation in Oncology
- (2017) Sean Khozin et al. JNCI-Journal of the National Cancer Institute
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-World Evidence — What Is It and What Can It Tell Us?
- (2016) Rachel E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The performance of different propensity score methods for estimating absolute effects of treatments on survival outcomes: A simulation study
- (2016) Peter C Austin et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis
- (2016) Peter C. Austin STATISTICS IN MEDICINE
- The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes
- (2015) Peter C Austin et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
- (2015) Peter C. Austin et al. STATISTICS IN MEDICINE
- Optimizing the Leveraging of Real-World Data to Improve the Development and Use of Medicines
- (2015) Marc L. Berger et al. VALUE IN HEALTH
- The performance of different propensity score methods for estimating marginal hazard ratios
- (2012) Peter C. Austin STATISTICS IN MEDICINE
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- (2011) Peter C. Austin MULTIVARIATE BEHAVIORAL RESEARCH
- Implications of Bone-Only Metastases in Breast Cancer: Favorable Preference with Excellent Outcomes of Hormone Receptor Positive Breast Cancer
- (2011) Su Jin Lee et al. Cancer Research and Treatment
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started